Cancer drug pelabresib gets Long-Term safety check in extension trial

NCT ID NCT06401356

Recruiting now Disease control Sponsor: Novartis Pharmaceuticals Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at the long-term safety and benefits of the drug pelabresib in people with blood cancers, solid tumors, or advanced cancers. It includes up to 50 adults who were in earlier pelabresib studies and are still benefiting from the drug. Some participants who received placebo or stopped pelabresib may also join to track survival over time.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cancer hematopoietic and lymphoid cell neoplasm hematopoietic and lymphoid system neoplasm neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ADVANCED MALIGNANCIES HEMATOLOGIC MALIGNANCY SOLID TUMOR

Contacts and locations

Locations

Mayo Clinic Jacksonville
RECRUITING

Jacksonville, Florida, 32224, United States
Mt Sinai Medical Center
RECRUITING

New York, New York, 10029-6574, United States
New York Presbyterian Hospital
RECRUITING

New York, New York, 10021, United States
Northwestern University
RECRUITING

Chicago, Illinois, 60611, United States
Novartis Investigative Site
RECRUITING

Antwerp, 2030, Belgium
Novartis Investigative Site
RECRUITING

Bruges, 8000, Belgium
Novartis Investigative Site
RECRUITING

Florence, FI, 50134, Italy
Novartis Investigative Site
RECRUITING

Varese, VA, 21100, Italy
Novartis Investigative Site
RECRUITING

Novara, 28100, Italy
Novartis Investigative Site
RECRUITING

Amsterdam, 1081, Netherlands
Novartis Investigative Site
RECRUITING

Cardiff, CF14 4XW, United Kingdom
Novartis Investigative Site
RECRUITING

Glasgow, G12 0YN, United Kingdom
Novartis Investigative Site
RECRUITING

London, SE1 7EH, United Kingdom
Uni Of Michigan Health System
RECRUITING

Ann Arbor, Michigan, 48109, United States
University of California LA
RECRUITING

Los Angeles, California, 90095, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.